Synthetic peptides derived from ribosomal proteins of leishmania spp. in mucocutaneous leishmaniasis: Diagnostic usefulness
Background: The serological diagnostic methods currently available for mucocutaneous leishmaniasis (MCL) lack specificity when complete parasites are used; however, such specificity increases when protein fractions are used. Ribosomal proteins have been reported to induce antibodies in animal and hu...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22889
- Acceso en línea:
- https://doi.org/10.2174/0929866524666170728143924
https://repository.urosario.edu.co/handle/10336/22889
- Palabra clave:
- Immunoglobulin g antibody
Ribosome protein
Unclassified drug
Peptide
Protozoal protein
Ribosome protein
Antibody detection
Autoimmune disease
Chagas disease
Clinical article
Controlled study
Enzyme linked immunosorbent assay
Informed consent
Leishmania braziliensis
Mucocutaneous leishmaniasis
Predictive value
Protein function
Sensitivity and specificity
Serodiagnosis
Skin leishmaniasis
Amino acid sequence
Autoimmune disease
Chagas disease
Cross reaction
Immunology
Serology
Skin leishmaniasis
Amino acid sequence
Autoimmune diseases
Chagas disease
Cross reactions
Enzyme-linked immunosorbent assay
mucocutaneous
Leishmania braziliensis
Peptides
Protozoan proteins
Ribosomal proteins
Sensitivity and specificity
Serologic tests
Diagnosis
Leishmania braziliensis
Mucocutaneous leishmaniasis
Ribosomal protein
Synthetic peptide
mucocutaneous
- Rights
- License
- Abierto (Texto Completo)